# Randi Y. Leavitt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/randi-y-leavitt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,465 |
| Field | HIV/AIDS drug development and treatment |
| h-index | 50 |
| i10-index | 72 |
| Last Known Institution | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| OpenAlex ID | https://openalex.org/A5004089973 |
| Works | 97 |

## Researcher papers

- [Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation](https://scholariq.org/papers/letermovir-prophylaxis-for-cytomegalovirus-in-hematopoietic-cell-transplantation/)
- [Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults](https://scholariq.org/papers/safety-and-immunogenicity-of-a-replication-incompetent-adenovirus-type-5-hiv-1/)

## Researcher topics

- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)

## Researcher university

- [Merck & Co., Inc., Rahway, NJ, USA (United States)](https://scholariq.org/institutions/merck-and-co-inc-rahway-nj-usa-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.